Steinkraus V, Mensing H
Hautklinik Universitäts-Krankenhaus Hamburg-Eppendorf.
Hautarzt. 1992 Apr;43(4):179-83.
Psoriasiform skin eruptions during treatment with beta-adrenergic blocking drugs have recently attracted increasing attention and led the Bundesgesundheitsamt [German Office of Public Health] to publish general information on this issue. Today's knowledge on the clinical picture, pharmacology, and the pathogenesis is discussed, with reference to the latest experimental data. The blockade of keratinocyte beta-adrenergic receptors may play a key role in the aetiopathology of this unwanted side-effect.